Clinical Trials Browser

Treatment-Refractory Solid Tumors × atezolizumab × 1 year × Clear all

NCT07190833 2025-09-24

A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)

Phase 1 Not yet recruiting

Other solid neoplasm

Treatment-Refractory Solid Tumors